Etamivan

General information

Etamivan has actions similar to doxapram hydrochloride and has been used as a respiratory stimulant [ ], for example in patients with respiratory failure [ ], hypoventilation during thoracic surgery [ ], postsurgical respiratory depression [ ], perinatal asphyxia [ ], and barbiturate poisoning [ , ]. However, it has a low therapeutic index and the incidence of adverse effects from intravenous etamivan is high [ ]. Laryngospasm, sneezing, and substernal chest pain have been among the reactions recorded after intravenous infusion.